» Authors » Jens Uwe Blohmer

Jens Uwe Blohmer

Explore the profile of Jens Uwe Blohmer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 344
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
von Minckwitz G, Uwe Blohmer J, Costa S, Denkert C, Eidtmann H, Eiermann W, et al.
J Clin Oncol . 2013 Sep; 31(29):3623-30. PMID: 24002511
Purpose: We investigated disease-free survival (DFS) and overall survival (OS) after response-guided neoadjuvant chemotherapy in patients with early breast cancer. Patients And Methods: We treated 2,072 patients with two cycles...
12.
von Minckwitz G, Muller B, Loibl S, Budczies J, Hanusch C, Darb-Esfahani S, et al.
J Clin Oncol . 2011 Apr; 29(16):2150-7. PMID: 21519019
Purpose: Poly(adenosine diphosphate-ribose) polymerase (PARP) plays a key role in DNA repair and cellular stress response. Inhibitors of PARP show promising clinical activity in metastatic, triple-negative or BRCA-mutated breast cancer....
13.
Darb-Esfahani S, Loibl S, Muller B, Roller M, Denkert C, Komor M, et al.
Breast Cancer Res . 2009 Sep; 11(5):R69. PMID: 19758440
Introduction: Reliable predictive and prognostic markers for routine diagnostic purposes are needed for breast cancer patients treated with neoadjuvant chemotherapy. We evaluated protein biomarkers in a cohort of 116 participants...
14.
Uwe Blohmer J, Kimmig R, Kummel S, Costa S, Kramer S, Rezai M
Gynakol Geburtshilfliche Rundsch . 2008 Apr; 48(2):63-7. PMID: 18431045
In the systemic therapy of breast cancer, the tumor itself has become the specific target. If possible the surgical excision of breast carcinoma is restricted to the tumor site and...
15.
Paepke S, Jacobs V, Paepke D, Euler U, Uwe Blohmer J, Warm M, et al.
Onkologie . 2006 May; 29(5):210-7. PMID: 16679783
Even in elderly patients, greater consideration is now being given to tumor volume reduction in locally advanced breast cancer, with increased subsequent breast-conserving surgery. Neoadjuvant endocrine therapy offers the possibility...
16.
Jackisch C, von Minckwitz G, Eidtmann H, Costa S, Raab G, Uwe Blohmer J, et al.
Clin Breast Cancer . 2002 Nov; 3(4):276-80. PMID: 12425756
Timing of systemic treatment in primary operable breast cancer is subject to extensive investigation, suggesting that pathologic complete remission (pCR) might improve survival in this setting. The German Adjuvant Breast...